Production of intermediates for e.g. fluoxetine synthesis comprises asymmetric catalytic reduction based on oxazaborolidine giving high product yield
NOVELTY – The production of intermediates for e.g. fluoxetine synthesis has asymmetric catalytic reduction via oxazaborolidinee of (+) and (-)-3-exo-amino-7,7-dimethoxynorboman-2-exo-ol. 3-chloro-1-phenyl-1-propanol enriched enantiomerically on recrystallisation in hexane yields the alcohol in 98 per cent enantiomeric excess.
Main Application Field
B05 (Other organics – aromatics, aliphatic, organo-metallics, compounds whose substituents vary such that they would be classified in several of B01 – B05.)
INVENTORS:
PILLI RONALDO ALOISE
LAPIS ALEXANDRE AUGUSTO MOREIRA
COSTA VALENTIM EMILIO UBERTI
_
Patent number: BR200306242-A;BR200306242-B1
PATENT STATUS:
GRANTED
FOR ADDITIONAL INFORMATION:
parcerias@inova.unicamp.br
+55 (19) 3521-5207 / 2607
This technology profile has been automatically generated.